DK526689A - Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade - Google Patents

Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade

Info

Publication number
DK526689A
DK526689A DK526689A DK526689A DK526689A DK 526689 A DK526689 A DK 526689A DK 526689 A DK526689 A DK 526689A DK 526689 A DK526689 A DK 526689A DK 526689 A DK526689 A DK 526689A
Authority
DK
Denmark
Prior art keywords
pheumonia
relations
formulations
diseases
procedures
Prior art date
Application number
DK526689A
Other languages
Danish (da)
English (en)
Other versions
DK526689D0 (da
Inventor
Richard R Tidwell
J Dieter Geratz
James Edwin Hall
Dennis E Kyle
Max Grogl
Kwasi A Ohemeng
Original Assignee
Richard R Tidwell
J Dieter Geratz
Kwasi A Ohemeng
James Edwin Hall
Dennis E Kyle
Max Grogl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/262,324 external-priority patent/US4963589A/en
Priority claimed from US07/262,535 external-priority patent/US4933347A/en
Priority claimed from US07/334,730 external-priority patent/US5202320A/en
Application filed by Richard R Tidwell, J Dieter Geratz, Kwasi A Ohemeng, James Edwin Hall, Dennis E Kyle, Max Grogl filed Critical Richard R Tidwell
Publication of DK526689D0 publication Critical patent/DK526689D0/da
Publication of DK526689A publication Critical patent/DK526689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK526689A 1988-10-25 1989-10-24 Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade DK526689A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/262,324 US4963589A (en) 1988-10-25 1988-10-25 Methods for treating Giardia lamblia
US07/262,535 US4933347A (en) 1988-10-25 1988-10-25 Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
US33459089A 1989-04-06 1989-04-06
US07/334,730 US5202320A (en) 1989-04-06 1989-04-06 Method for treating leishmaniasis

Publications (2)

Publication Number Publication Date
DK526689D0 DK526689D0 (da) 1989-10-24
DK526689A true DK526689A (da) 1990-04-26

Family

ID=27500733

Family Applications (1)

Application Number Title Priority Date Filing Date
DK526689A DK526689A (da) 1988-10-25 1989-10-24 Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade

Country Status (13)

Country Link
EP (1) EP0366066B1 (pt)
JP (1) JP2887397B2 (pt)
AR (1) AR248011A1 (pt)
AT (1) ATE119147T1 (pt)
AU (1) AU626033B2 (pt)
BR (1) BR8905441A (pt)
CA (1) CA2001359C (pt)
CH (1) CH679857A5 (pt)
DE (1) DE68921413T2 (pt)
DK (1) DK526689A (pt)
FI (1) FI895039A0 (pt)
IL (1) IL92101A (pt)
NO (1) NO894222L (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
ES2075672T3 (es) * 1991-06-11 1995-10-01 Ciba Geigy Ag Amidinocompuestos, su fabricacion y uso como medicamento.
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
US5488160A (en) * 1991-06-11 1996-01-30 Ciba-Geigy Corporation Amidino compounds, their manufacture and method of treatment
CZ287209B6 (en) * 1992-02-05 2000-10-11 Boehringer Ingelheim Kg Amidine derivatives, process of their preparation and pharmaceutical preparations containing thereof
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
US5629348A (en) * 1994-11-14 1997-05-13 Nzym, Inc. Methods and compositions for treating septoria infections
AU4107796A (en) * 1994-11-14 1996-06-06 Nzym, Inc. Methods and compositions for treating phytopathogenic fungi infections
US5723495A (en) 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
ES2198139T3 (es) 1998-08-20 2004-01-16 The University Of North Carolina At Chapel Hill Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.
DE19853944A1 (de) * 1998-11-24 2000-05-25 Bourdichon Alain Jacques Verwendung von Diminazen-di-aceturat zur Behandlung von Malaria
WO2005089738A2 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
RU2620016C1 (ru) * 2016-03-28 2017-05-22 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Способ профилактики пневмоцистной пневмонииии у реципиентов сердца в раннем послеоперационном периоде после трансплантации сердца

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2277861A (en) * 1937-12-10 1942-03-31 May & Baker Ltd Process for the preparation of diamidine derivatives
FR925999A (fr) * 1945-03-22 1947-09-18 May & Baker Ltd Procédé de préparation d'amidines

Also Published As

Publication number Publication date
CA2001359C (en) 1997-05-06
FI895039A0 (fi) 1989-10-24
NO894222D0 (no) 1989-10-24
CA2001359A1 (en) 1990-04-25
IL92101A (en) 1995-11-27
DE68921413T2 (de) 1995-06-29
DK526689D0 (da) 1989-10-24
AU4366789A (en) 1990-05-03
AR248011A1 (es) 1995-05-31
CH679857A5 (pt) 1992-04-30
NO894222L (no) 1990-04-26
AU626033B2 (en) 1992-07-23
ATE119147T1 (de) 1995-03-15
JPH02243666A (ja) 1990-09-27
DE68921413D1 (de) 1995-04-06
EP0366066B1 (en) 1995-03-01
EP0366066A1 (en) 1990-05-02
JP2887397B2 (ja) 1999-04-26
BR8905441A (pt) 1990-10-23

Similar Documents

Publication Publication Date Title
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK526689D0 (da) Fremgangsmaade til behandling og forebyggelse af pneumocystis carinii pheumonia og andre sygdomme, og forbindelser og formuleringer til anvendelse ved denne fremgangsmaade
NO911694L (no) Mikroemulsjonsblanding til haarbehandling, fremgangsmaate for fremstilling og anvendelse derav.
NO871978D0 (no) Ekstrakter av nerium-arter, og fremgangsmaate for fremstilling av bruk av disse.
NO164219C (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
DK554485D0 (da) Geltandplejemiddel og fremgangsmaade til fremstilling deraf
DK360587A (da) Fremgangsmaade til bestemmelse af okkult blod og kemiske midler til anvendelse ved fremgangsmaaden
NO890643L (no) Fremgangsmaate ved behandling av avluft og avgass.
DK341489D0 (da) Fremgangsmaade til fremstilling af praeparater til anvendelse af biologiske aktive peptider til rektale og vaginale formaal
DK365489A (da) Fremgangsmaade til diagnostisering af hiv-infektion og diagnostiseringsapparat til anvendelse ved fremgangsmaaden
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK148389D0 (da) Fremgangsmaade til fremstilling af polydichlorphosphazenpraeparater og de ved fremgangsmaaden fremstillede praeparater
DK641189A (da) Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat
DK165475C (da) Fremgangsmaade og anlaeg til behandling eller undersoegelse af slagtekroppe
NO873274L (no) Tettet roerskjoet og fremgangsmaate for dannelse av denne.
DK45289D0 (da) Fremgangsmaade og anlaeg til behandling af maelk
DK163189D0 (da) Fremgangsmaade og anlaeg til behandling af slamformigt affald
NO892044D0 (no) Fremgangsmaate og anlegg for behandling av borekaks.
DK484688D0 (da) Fremgangsmaade til behandling af mastitis og andre staphylococcusinfektioner
DK123090D0 (da) Fremgangsmaade ved dyrkning, indhoestning og efterbehandling af hyben samt apparater til udoevelse af fremgangsmaaden
NO875144L (no) Plant, terapeutisk system, fremgangsmÿte for fremstilling og anvendelse derav.
DK556589A (da) Ikke-reverterende levende shigellavaccine og fremgangsmaade til fremstilling heraf
NO893188L (no) Vevnad og fremgangsmaate for fremstilling av denne.
NO882843L (no) Humane pankreas-sekretoriske trypsin-inhibitorer fremstilt ved rekombinant-dna-metoder og fremgangsmaater til fremstilling av disse.
DK208688A (da) Hjoernesamling til bjaelker, navnlig af limtrae, og fremgangsmaade til dannelse af en saadan samling

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment